Accredited clinical laboratory and life sciences company

2013

Suchanek S, Majek O, Vojtechova G, Minarikova P, Rotnaglova B, Seifert B, Minarik M, Kozeny P, Dusek L, Zavoral M. Colorectal cancer prevention in the Czech Republic: time trends in performance indicators and current situation after 10 years of screening. Eur J Cancer Prev. 2013, 23, 18-26.


Fiala O, Pesek M, Finek J, Krejci J, Havel L, Hrnciarik M, Salajka F, Bortlicek Z, Benesova L, Minarik M. Erlotinib in the treatment of advanced squamous cell NSCLC. Neoplasma. 2013;60(6):676-82. doi: 10.4149/neo_2013_086.


Fiala O, Pesek M, Finek J, Benesova L, Bortlicek Z, Minarik M. Sequential treatment of advanced-stage lung adenocarcinoma harboring wild-type EGFR gene: second-line pemetrexed followed by third-line erlotinib versus the reverse sequence. Anticancer Res. 2013 Aug;33(8):3397-402.


Fiala O, Pesek M, Finek J, Benesova L, Bortlicek Z, Minarik M. Comparison of EGFR-TKI and chemotherapy in the first-line treatment of advanced EGFR mutation-positive NSCLC. Neoplasma. 2013;60(4):425-31. doi: 10.4149/neo_2013_055.


Fiala O, Pesek M, Finek J, Benesova L, Bortlicek Z, Minarik M. Gene mutations in squamous cell NSCLC: insignificance of EGFR, KRAS and PIK3CA mutations in prediction of EGFR-TKI treatment efficacy. Anticancer Res. 2013 Apr;33(4):1705-11.


Fiala O, Pesek M, Finek J, Benesova L, Belsanova B, Minarik M. The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. Cancer Genet. 2013, 206, 26-31.


Fiala O, Pesek M, Finek J, Krejci J, Bortlicek Z, Benesova L, Minarik M. Second line treatment in advanced non-small cell lung cancer (NSCLC): comparison of efficacy of erlotinib and chemotherapy. Neoplasma. 2013;60(2):129-34.


Fiala O, Pesek M, Finek J, Krejci J, Ricar J, Bortlicek Z, Benesova L, Minarik M. Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practice. Neoplasma. 2013;60:26-32.


Paulu P, Osmancik P, Tousek P, Minarik M, Benesova L, Motovska Z, Bednar F, Kocka V, Widimsky P. Lack of association between clopidogrel responsiveness tested using point-of-care assay and prognosis of patients with coronary artery disease. J Thromb Thrombolysis. 2013 Jul;36(1):1-6. doi: 10.1007/s11239-012-0813-8.


Benesova L, Belsanova B, Minarikova P, Suchanek S, Kopeckova M, Levy M, Lipska L, Visokai V, Zavoral M, Minarik M. Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients. Anal Biochem 2013, 433:227-34. IF 3,236